Stereotactic Body Radiation Therapy (SBRT)

AUG 18, 2026 · PHASE 2 TRIAL

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

ClinicalTrials.gov

This is a Phase 2, single-arm feasibility study with no results yet posted; it is designed to evaluate concurrent SBRT and immunotherapy but carries no outcome data to assess efficacy or safety.

AUG 14, 2026 · PHASE 2 TRIAL

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no posted results; it describes a planned study of neoadjuvant SBRT plus chemotherapy and immunotherapy in HR+/HER2− breast cancer, currently recruiting 27 participants.